- Home
- ADN vs ADXN Comparison
ADN vs ADXN Comparison
Compare ADN & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADN
- ADXN
- Stock Information
- Founded
- ADN 2006
- ADXN 2002
- Country
- ADN United States
- ADXN Switzerland
- Employees
- ADN N/A
- ADXN N/A
- Industry
- ADN Power Generation
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- ADN Utilities
- ADXN Health Care
- Exchange
- ADN Nasdaq
- ADXN Nasdaq
- Market Cap
- ADN 7.5M
- ADXN 8.1M
- IPO Year
- ADN N/A
- ADXN N/A
- Fundamental
- Price
- ADN $2.46
- ADXN $8.12
- Analyst Decision
- ADN
- ADXN Strong Buy
- Analyst Count
- ADN 0
- ADXN 1
- Target Price
- ADN N/A
- ADXN $30.00
- AVG Volume (30 Days)
- ADN 46.6K
- ADXN 3.0K
- Earning Date
- ADN 12-27-2024
- ADXN 06-05-2025
- Dividend Yield
- ADN N/A
- ADXN N/A
- EPS Growth
- ADN N/A
- ADXN N/A
- EPS
- ADN N/A
- ADXN 0.06
- Revenue
- ADN $8,157,000.00
- ADXN $701,260.00
- Revenue This Year
- ADN $2,232.99
- ADXN N/A
- Revenue Next Year
- ADN $91.56
- ADXN N/A
- P/E Ratio
- ADN N/A
- ADXN $1.06
- Revenue Growth
- ADN 274.35
- ADXN N/A
- 52 Week Low
- ADN $1.71
- ADXN $6.51
- 52 Week High
- ADN $8.79
- ADXN $13.27
- Technical
- Relative Strength Index (RSI)
- ADN 42.46
- ADXN 54.21
- Support Level
- ADN $2.60
- ADXN $7.70
- Resistance Level
- ADN $2.85
- ADXN $8.38
- Average True Range (ATR)
- ADN 0.40
- ADXN 0.32
- MACD
- ADN 0.07
- ADXN 0.01
- Stochastic Oscillator
- ADN 28.37
- ADXN 59.13
About ADN Advent Technologies Holdings Inc.
Advent Technologies Holdings Inc is an innovation-driven company in the fuel cell and hydrogen technology space. The company develops, manufactures, and assembles complete fuel cell systems and the critical components that determine the performance of hydrogen fuel cells and other energy systems. It serves automotive; aviation and power generation industries. It generates revenue from the sale of fuel cell systems and the sale of MEAs, membranes, and electrodes for specific applications in the fuel cell and energy storage (flow battery) markets.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.